D

DEFTA Partners

18 employees

DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage

Investor insights

Sectors invested in

Medical13
Biotechnology12
Health Care10
Software7
Therapeutics6
Artificial Intelligence5
Machine Learning4
Health and Wellness3
Tissue Engineering3
Molecular Biology3
Pluripotent Stem Cells3
iPSC3
Stem Cell Research3
Personal Health3
Regenerative Medicine3
DNA3
DNA test3
Personalized Medicine3
Ultrasound2
Ultrasound Analysis2

Funding rounds participated in

$1.8M sweet spot round size

Most of their 27 investments are in rounds between $6.5M and $14M

Investor type

Micro VC

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Private Equity
Healthcare
Information Technology
Venture Capital
Life Science

Date founded

1985

Investments made

E

Endogena Therapeutics, Inc. raised $21M on December 13, 2021

Investors: Rejuveron Life Sciences AG and DEFTA Partners

D

DiA Imaging Analysis raised $14M on August 24, 2021

Investors: Mindset Ventures, XTX Ventures, Alchimia Investments, CE Ventures and DEFTA Partners

I

InformAI raised $1.5M on May 1, 2021

Investors: Delight Ventures and DEFTA Partners

E

Endogena Therapeutics, Inc. raised $8M on January 28, 2021

Investors: Rejuveron Life Sciences AG and DEFTA Partners

A

Aegle Therapeutics raised $6.5M on September 29, 2020

Investors: New World Angels, Tellus BioVentures, Ocean Azul Partners, FAN Fund and DEFTA Partners

I

InformAI raised $1.8M on June 26, 2020

Investors: Social Starts, Joyance Partners and DEFTA Partners

T

TARA Biosystems, Inc. raised $10M on June 23, 2020

Investors: OMX Ventures, Partnership for New York City, Lifeforce Capital, Merieux Equity Partners and DEFTA Partners

A

Aegle Therapeutics raised $4M on January 9, 2020

Investors: Ocean Azul Partners, -, FAN Fund, New World Angels and DEFTA Partners

A

Actuate Therapeutics, Inc. raised $6.5M on November 12, 2019

Investors: Bios Partners, Kairos Ventures and DEFTA Partners

B

BioEclipse Therapeutics, Inc raised $7.7M on June 24, 2019

Investors: Revelis Capital Group, TSVC, Foothill Ventures, Plum Alley Investments and DEFTA Partners

FAQ